العودة إلى الصفحة الرئيسية
820К+ مريضًا حصلوا على المساعدة منذ عام 2014
50 دول
1,500 عيادات
6K+ تقييمات
3K+ طبيب مؤهل

ما هي تكلفة مرض الزهايمر إجراءات التشخيص والعلاج في قبرص؟ اعرف الآن

السعر يقدم بعد الطلب
قبرصتركياإسبانيا
علاج الخلايا الجذعية لمرض الزهايمر-من $15,000من $20,000
تم التحقق من البيانات بواسطة Bookimed اعتبارًا من August 2026، استنادًا إلى طلبات المرضى والعروض الرسمية من 147 عيادة حول العالم. تستند التكاليف المتوسطة إلى الفواتير الحقيقية (2025–2026) ويتم تحديثها شهريًا. قد تختلف الأسعار الفعلية.

مزاياك وضماناتك مع Bookimed

أسعار مباشرة

Bookimed لا يضيف رسوماً إضافية على أسعار علاج مرض الزهايمر. الأسعار مأخوذة من قوائم الأسعار الرسمية للعيادات. تدفع مباشرة في العيادة مقابل علاجك عند وصولك إلى البلد.

عيادات وأطباء معتمدون فقط

Bookimed ملتزم بسلامتك. نحن نعمل فقط مع المؤسسات الطبية التي تحافظ على معايير دولية عالية في علاج مرض الزهايمر ولديها التراخيص اللازمة لخدمة المرضى الدوليين في جميع أنحاء العالم.

مساعدة مجانية على مدار الساعة

Bookimed يقدم مساعدة خبراء مجانية. منسق طبي شخصي يدعمك قبل وأثناء وبعد العلاج، ويحل أي مشاكل. لن تكون وحيداً أبداً في رحلة علاج مرض الزهايمر.

لماذا نحن؟

منسقك الطبي الشخصي في Bookimed

  • يدعمك في كل مرحلة
  • المساعدة في اختيار العيادة الطبية المناسبة والطبيب المناسب
  • يضمن الوصول السريع والمريح إلى المعلومات

مشاركة المحتوى

Twitter XLinkedinFacebookWhatsAppEmail
أحصل على الرابط

قصص فيديو من مرضى Bookimed

Dayana
جمعت بين إجازتي في أنطاليا والفحص الطبي.
إجراء: فحص صحة الإناث (انظر فحص النساء)
Igor
كان رائعاً! التنقلات والإقامة والعلاج - كل شيء مشمول.
إجراء: زرع الأسنان
مستشفى: WestDent Clinic
Marina
قام Bookimed بكل شيء من أجلي. لم أضطر للقلق بشأن أي شيء.
إجراء: فحص صحة الإناث (انظر فحص النساء)
مستشفى: Severance Hospital
محدث: 01/08/2025
تأليف
Anna Leonova
Anna Leonova
رئيس فريق تسويق المحتوى
محررة طبية معتمدة لديها خبرة تزيد عن 10 سنوات، طوّرت محتوى Bookimed الموثوق، مدعومة بماجستير في علم اللغة ومقابلات مع خبراء طبيين من جميع أنحاء العالم.
تمت المراجعة من قبل المستشار الطبي في Bookimed
فهد مولود
محرر طبي وعالم بيانات
طبيب عام. حاصل على 4 جوائز علمية. خدم في غرب آسيا. رئيس الفريق الطبي الناطق بالعربية سابقا ومسؤول عن معالجة البيانات ودقة المحتوى الطبي حاليا.
فهد مولود Linkedin
قد تحتوي هذه الصفحة على معلومات تتعلق بمختلف الحالات الطبية والعلاجات وخدمات الرعاية الصحية المتوفرة في بلدان مختلفة. يرجى العلم أن المحتوى مقدم لأغراض إعلامية فقط ولا ينبغي تفسيره على أنه نصيحة أو إرشادات طبية. يرجى استشارة طبيبك أو أخصائي طبي مؤهل قبل البدء أو تغيير العلاج الطبي.

أسئلة متكررة حول علاج مرض الزهايمر في قبرص

هذه الأسئلة الشائعة مأخوذة من مرضى حقيقيين يبحثون عن رعاية طبية عبر Bookimed. يتم تقديم الإجابات من قبل منسقين طبيين ذوي خبرة وممثلين موثوقين من العيادات.

What advanced or disease-modifying Alzheimer's treatments are available in Cyprus?

Cyprus follows European Union regulations for advanced Alzheimer's treatments like monoclonal antibodies. Legal authorization exists for drugs like lecanemab. However, practical availability in the public health system remains limited. Access requires confirmed amyloid pathology through specialized PET scans or lumbar punctures.

  • Regulatory framework: European Commission marketing authorizations apply to all member states.
  • Access requirements: Patients must have confirmed early-stage Alzheimer's or mild dementia.
  • Safety monitoring: Specialized clinics must perform regular MRI scans to monitor patients.
  • Public coverage: National healthcare system reimbursement typically involves long health technology assessments.

Bookimed Expert Insight: While German Medical Institute in Cyprus holds CHKS and ISO 45001:2018 certifications, advanced biological infusions are rare in local private clinics. Most regional specialists focus on diagnostic accuracy using nuclear medicine. Patients should verify if a clinic provides serial MRI monitoring before starting any infusion therapy.

Patient Consensus: Patients note that finding neurologists who coordinate evidence-based monitoring is more important than local drug availability. Many express caution regarding private clinics offering unproven infusion therapies or apheresis without clinical evidence.

Who is eligible for breakthrough amyloid-targeting therapies in Cyprus?

Eligibility for breakthrough amyloid-targeting therapies in Cyprus requires a diagnosis of early-stage Alzheimer disease. Patients must show mild cognitive impairment or mild dementia. Diagnosis requires biomarker evidence from PET scans or spinal fluid analysis. Special authorization from Pharmaceutical Services is necessary for importation.

  • Disease stage: Therapy is limited to mild cognitive impairment or mild dementia stages.
  • Amyloid confirmation: Testing must confirm beta-amyloid plaques via PET imaging or fluid analysis.
  • Safety monitoring: Candidates must undergo frequent MRI scans to track potential brain swelling.
  • Vascular health: Patients with high stroke or hemorrhage risk are typically excluded.

Bookimed Expert Insight: While German Medical Institute (GMI) holds CHKS and ISO 45001:2018 certifications, these advanced therapies are often handled through individual case evaluations. Patients should prepare cognitive records early. The clinic serves over 13,000 patients annually. This volume suggests high diagnostic capacity for complex neurological screenings.

Patient Consensus: Patients note that access is strictly referral-driven through the General Healthcare System (GESY). They emphasize bringing all previous testing records to the initial specialist consultation to avoid delays.

Where can patients receive specialized neurological evaluations or Alzheimer's care in Cyprus?

Patients can access specialized Alzheimer's care at the Cyprus Institute of Neurology and Genetics in Nicosia. The German Medical Institute in Limassol also offers neurological diagnostic pathways. These centers provide cognitive evaluations, genetic testing, and innovative neuromodulation therapies like Transcranial Pulse Stimulation.

  • Specialized diagnostic centers: Nicosia serves as the primary hub for complex neurological evaluations and genetic diagnostics.
  • Private facility access: German Medical Institute handles approximately 13,700 adult patients annually across 29 medical departments.
  • Innovative therapy options: Specialized hubs in Limassol offer non-invasive brain stimulation for neurodegenerative conditions.
  • Accreditation and quality: Top private centers hold CHKS and ISO 45001:2018 certifications for safety.

Bookimed Expert Insight: Private hospitals like the German Medical Institute offer faster access to specialists for diagnostic reviews. This facility employs 90 doctors with training from Germany and the United Kingdom. Their multilingual team helps bridge communication gaps for international patients seeking second opinions on dementia. Coordination through these centers often reduces the month-long wait times seen at public institutes.

Patient Consensus: Patients note that private clinics in Limassol are much faster for scheduling initial specialist consultations. Many recommend starting with a formal diagnosis in Nicosia before arranging home nursing support locally.

What support and non-pharmacological care do local associations provide?

Local associations in Cyprus provide non-pharmacological Alzheimer's care through psychosocial support, caregiver education, and resource navigation. These organizations offer peer-led groups, stress management workshops, and referrals to essential community services. They focus on reducing caregiver isolation and improving daily life for patients without relying on medication.

  • Peer support: Facilitator-led groups share coping strategies to build emotional resilience.
  • Caregiver education: Workshops teach behavioral management and techniques to prevent burnout.
  • Resource navigation: Associations connect families with food support, transport, and legal aid.
  • Wellness activities: Groups organize adaptive movement and social classes for holistic wellbeing.

Bookimed Expert Insight: While German Medical Institute (GMI) serves 13,700 patients annually with ISO-certified quality, medical centers often focus on diagnostics. Real support for chronic care happens locally. Families should prioritize clinics with multilingual teams in Greek and English. This ensures seamless communication when coordinating with local NGOs or government departments for long-term respite care.

Patient Consensus: Families emphasize using local church networks and municipal helplines for practical help. Many find that confidential emotional support from organizations like the Samaritans is vital when they feel overwhelmed by daily caregiving tasks.

Are standard medications and care costs covered by the Cypriot public healthcare system (GESY)?

Standard medications and care for Alzheimer's are heavily covered by the Cypriot public healthcare system (GESY). The system uses a low-copayment model. Hospital stays and surgeries are completely free. Patients pay small fees for prescriptions and specialist visits. Beneficiaries must register with a personal doctor.

  • Specialist visits: Consultations cost 6 euros with a referral from a personal doctor.
  • Medication costs: Formulary drugs carry a flat 1 euro copayment per product.
  • Diagnostic imaging: Laboratory tests and scans typically cost 1 euro per test.
  • Spending cap: Annual out-of-pocket costs are limited to 150 euros for most adults.

Bookimed Expert Insight: Cyprus provides high-quality infrastructure for complex cases at centers like German Medical Institute (GMI). While public coverage is broad, GMI treats over 13,000 patients annually using German-trained specialists. Patients seeking advanced diagnostics should ensure their personal doctor provides a GESY referral to maintain low costs.

Patient Consensus: Patients note that while standard visits and common medications are very affordable, newer branded drugs sometimes require private payment. It is important to confirm eligibility based on residence status before starting long-term Alzheimer's treatment.

احصل على استشارة مجانية

حدد أفضل طريقة للاتصال بك